CERAMENT® G | The Burden of Bone Infection

The Burden of Bone Infection

CERAMENT^® G is the first and only injectable antibiotic eluting bone graft indicated for use in the management of bone infection.

Despite medical advancements and use of systemic antibiotics, bone infection remains a challenge. Moreover, bone infections are associated with an increased risk of amputation.

1 in 5 infections recur¹
2+ surgical interventions typically required²
20 – 30% long term recurrence rate³
$51K more treatment costs for infected patients⁴

Conterno, L.O., Turchi, M.D. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2013;2013(9).
Bezstarosti et al. Insights into treatment and outcome of fracture-related infection:
a systematic literature review. Arch Orthop Trauma Surg 139, 61–72 (2019).
Pande K. Optimal management of chronic osteomyelitis: current perspectives. Orthop Res Rev. 2015;7:71-81.
Thakore et al. Sethi MK. Surgical site infection in orthopedic trauma: A case-control study evaluating risk factors and cost.
J Clin Orthop Trauma. 2015 Dec;6(4):220-6. doi: 10.1016/j.jcot.2015.04.004.
Epub 2015 Jun 18. PMID: 26566333; PMCID: PMC4600831.